Clinical trial
Randomisation to Endoluminal Intestinal Liner Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)
NCT02055014 is registered in ClinicalTrials.gov with Sandwell & West Birmingham Hospitals NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomisation to Endoluminal Intestinal Liner Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)
- Lead sponsor
- Sandwell & West Birmingham Hospitals NHS Trust
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 31, 2013
- Completion date
- March 31, 2017
- Enrollment
- 72 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.